• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Swedish Orphan Biovitrum AB

+ Add to Watchlist

B6E:GR

9.259 EUR 0.030 0.32%

As of 11:09:58 ET on 07/11/2014.

Snapshot for Swedish Orphan Biovitrum AB (B6E)

Open: 9.213 Day's Range: 9.181 - 9.486 Volume: 0
Previous Close: 9.289 52wk Range: 5.152 - 10.150 1-Yr Rtn: +78.81%

Stock Chart for B6E

No chart data available.
  • B6E:GR 9.259
  • 1D
  • 1M
  • 1Y
9.289
Interactive B6E Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B6E

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 417.5279
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 0.2050
Est. PEG Ratio -
Market Cap (M EUR) 2,508.94
Shares Outstanding (M) 270.39
30 Day Average Volume 597
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B6E

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for B6E

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for B6E

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil